Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
D-Pharm Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'D-Pharm Ltd. - Product Pipeline Review - 2014', provides an overview of the D-Pharm Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of D-Pharm Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of D-Pharm Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of D-Pharm Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the D-Pharm Ltd.'s pipeline products Reasons to buy - Evaluate D-Pharm Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of D-Pharm Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the D-Pharm Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of D-Pharm Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of D-Pharm Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of D-Pharm Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 D-Pharm Ltd. Snapshot 5 D-Pharm Ltd. Overview 5 Key Information 5 Key Facts 5 D-Pharm Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 D-Pharm Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 D-Pharm Ltd. - Pipeline Products Glance 10 D-Pharm Ltd. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 D-Pharm Ltd. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 D-Pharm Ltd. - Drug Profiles 13 DP-b99 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 DP-VPA 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 THR-18 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 DP-460 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 DP-NDD 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 D-Pharm Ltd. - Pipeline Analysis 21 D-Pharm Ltd. - Pipeline Products by Target 21 D-Pharm Ltd. - Pipeline Products by Route of Administration 22 D-Pharm Ltd. - Pipeline Products by Molecule Type 23 D-Pharm Ltd. - Pipeline Products by Mechanism of Action 24 D-Pharm Ltd. - Recent Pipeline Updates 25 D-Pharm Ltd. - Dormant Projects 29 D-Pharm Ltd. - Discontinued Pipeline Products 30 Discontinued Pipeline Product Profiles 30 DP-b99 30 D-Pharm Ltd. - Locations And Subsidiaries 31 Head Office 31 Other Locations & Subsidiaries 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 33 Disclaimer 33
List of Tables D-Pharm Ltd., Key Information 5 D-Pharm Ltd., Key Facts 5 D-Pharm Ltd. - Pipeline by Indication, 2014 7 D-Pharm Ltd. - Pipeline by Stage of Development, 2014 8 D-Pharm Ltd. - Monotherapy Products in Pipeline, 2014 9 D-Pharm Ltd. - Phase II, 2014 10 D-Pharm Ltd. - Phase I, 2014 11 D-Pharm Ltd. - Preclinical, 2014 12 D-Pharm Ltd. - Pipeline by Target, 2014 21 D-Pharm Ltd. - Pipeline by Route of Administration, 2014 22 D-Pharm Ltd. - Pipeline by Molecule Type, 2014 23 D-Pharm Ltd. - Pipeline Products by Mechanism of Action, 2014 24 D-Pharm Ltd. - Recent Pipeline Updates, 2014 25 D-Pharm Ltd. - Dormant Developmental Projects,2014 29 D-Pharm Ltd. - Discontinued Pipeline Products, 2014 30 D-Pharm Ltd., Other Locations 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.